Matches in Wikidata for { <http://www.wikidata.org/entity/Q65339510> ?p ?o ?g. }
Showing items 1 to 31 of
31
with 100 items per page.
- Q65339510 description "clinical trial" @default.
- Q65339510 description "ensayu clínicu" @default.
- Q65339510 description "klinisch onderzoek" @default.
- Q65339510 description "клінічне випробування" @default.
- Q65339510 name "Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors" @default.
- Q65339510 name "Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors" @default.
- Q65339510 type Item @default.
- Q65339510 label "Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors" @default.
- Q65339510 label "Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors" @default.
- Q65339510 prefLabel "Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors" @default.
- Q65339510 prefLabel "Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors" @default.
- Q65339510 P1132 Q65339510-B9C4F679-BBE4-4FB3-B038-835D120AD4E5 @default.
- Q65339510 P1476 Q65339510-EC5D591C-B126-47F2-893B-76BDAB2D8C85 @default.
- Q65339510 P17 Q65339510-B11FCB87-E585-4F1C-B9EC-13C83BA46537 @default.
- Q65339510 P2899 Q65339510-59FA7D2D-1B53-488F-9566-B290F0E10084 @default.
- Q65339510 P3098 Q65339510-9A6F7E3C-542A-40F8-827B-4168045F5F21 @default.
- Q65339510 P31 Q65339510-320D804C-25EE-49C7-834C-EA481B8D8DE6 @default.
- Q65339510 P580 Q65339510-08F04843-BD07-47A7-8860-93EAFB397664 @default.
- Q65339510 P582 Q65339510-DF3EA657-4977-49A9-B837-00B0CFEE8759 @default.
- Q65339510 P6099 Q65339510-C6667631-8889-4FB7-A701-0361B299D0D5 @default.
- Q65339510 P8363 Q65339510-788F5A99-A386-436C-A23B-42A81826E5CF @default.
- Q65339510 P1132 "+22" @default.
- Q65339510 P1476 "A Phase 1 Open-label First-in-human Dose-escalating Safety and Tolerability Study Evaluating Subcutaneous Administration of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy is Available" @default.
- Q65339510 P17 Q30 @default.
- Q65339510 P2899 "+18" @default.
- Q65339510 P3098 "NCT02508441" @default.
- Q65339510 P31 Q30612 @default.
- Q65339510 P580 "2015-12-08T00:00:00Z" @default.
- Q65339510 P582 "2017-11-13T00:00:00Z" @default.
- Q65339510 P6099 Q5452194 @default.
- Q65339510 P8363 Q78089383 @default.